echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Eight billion! Well-known arms enterprises and Alipay parent company cooperation.

    Eight billion! Well-known arms enterprises and Alipay parent company cooperation.

    • Last Update: 2020-09-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction: After the establishment of the gold company to carry out consumer finance-related business.
    . Recently, Fish Leap Medical announced that it intends to jointly invest RMB8 billion with Ant Technology Group Co., Ltd. (i.e., Ant Group), Beijing Chifang Technology Co., Ltd. to set up Chongqing Ant Consumer Finance Co., Ltd. ("Gold-eliminating Company") in Chongqing.
    , Fish Leap Medical, as a general funder, intends to contribute 399.2 million yuan with its own funds, accounting for 4.99% of the registered capital of the funding company.
    the establishment of the consumer finance-related business.
    it is understood that the deposit company refers to the non-bank financial institutions that provide consumers with loans for consumption purposes.
    Fish Leap Medical said that this out-of-country investment, is the company's consumer finance industry prospects under the premise of a careful assessment, taking into account the company as the largest domestic medical device company, consumer-oriented categories, especially higher-priced products, is very suitable for cooperation with the target company, in the form of consumer finance to give high-end medical devices to reach the public.
    according to the official website, Ant Group is China's largest mobile payment platform - Alipay's parent company, balance treasure, flowers, etc. are Ant Group products.
    33% of Ant Group's shareholders, Hangzhou Alibaba Net Technology Co., Ltd., is owned by Alibaba, according to the company.com.
    July 20, Ant Group said it would launch plans to seek simultaneous listings on the SSE's Kotson board and the HKEx's main board.
    August 24, the Zhejiang Securities Regulatory Commission disclosed in the evening that THECO and CITIC Jian investment on the Ant Group on the board of the guidance work has been completed.
    Ant Group is valued at $225 billion, according to blooming news agency and other media, and if the IPO is completed at that valuation, Ant Group will become the third-largest Internet company in china after Alibaba and Tencent.
    Investment is also one of the purposes of August 25, Cypress Blue Equipment was informed that the securities representative of Fish Leap Medical said that for the funding of the establishment of a gold-eliminating company, partly because of the fish-jumping medical part of the ventilator, oxygen machine and newly launched products, for some families, the price is not low, the establishment of a gold-cut company, consumers can through consumer finance, including flowers, loans and other installments to buy.
    as the product line expands, Fish Leap Medical hopes to enable more consumers to buy higher-priced products.
    Saibai Blue device query fish leap medical flagship store found that some of its products in the price of more than 10,000 yuan, such as a number of household ventilators, prices range from 7980 yuan to 15800 yuan.
    return on investment is also one of the purposes of this fish leap medical funding.
    said this is a better investment opportunity, because fish leap medical shares only 4.99 percent, although not involved in day-to-day management, but hope to participate in such a company, to obtain a certain return on investment.
    In addition, through the funding of the establishment of a gold-saving company, fish leap medical-related product design of the consumer program will be more flexible, previously in some e-commerce platform also has a fixed and relevant consumer finance program, but after the establishment of the gold-saving company, fish-jump medical may have some customized, for the company's products differentiation program.
    It is understood that Fish Leap Medical mainly provides home medical equipment and other products and services, products mainly concentrated in medical breathing and oxygen supply, home medical and chronic disease management, in-hospital disinfection sensing control, surgery and ophthalmology equipment and Chinese medicine equipment and other fields.
    August 15, Fish Leap Medical released its 2020 half-year report, showing that revenue in the first half of the year was about 3.42 billion yuan, up 36.74 percent year-on-year, and net profit from non-deduction was about 1.02 billion yuan, up 100.07 percent year-on-year. In terms of
    sub-products, in the first half of 2020, fish leap medical medical clinical products achieved revenue of about 756 million yuan, up 23.38% YoY;
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.